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Isoflavonoid Photoprotection in Mouse and Human
Skin Is Dependent on Metallothionein
Sitarina Widyarini1, Munif Allanson1, Nerida L. Gallagher1, Julie Pedley2, Glen M. Boyle2, Peter G. Parsons2,
David C. Whiteman2, Catherine Walker3 and Vivienne E. Reeve1
Previous studies report that selected topical isoflavonoids are immunoprotective in both mice and humans,
when applied following UV irradiation. Isoflavonoids have documented antioxidant activity, but their
mechanism of immunomodulation remains unclear. This study examines whether photoimmunoprotection
by the isoflavonoids might result from their interaction with one cutaneous antioxidant known to modulate UV
photodamage, metallothionein (MT). In mice bearing a null mutation for MT-I and -II, we found that
immunoprotection by the isoflavonoid 40,7-dihydroxyisoflavane (equol) against solar-simulated UV radiation
(SSUV) or exogenous cis-urocanic acid was abrogated. Topical equol did not activate MT expression in normal
mouse skin, but markedly enhanced the increase in MT expression in murine epidermis following SSUV
irradiation. Normal human skin, unlike murine, expressed MT in the basal epidermis. Following SSUV
irradiation, topical application of the related synthetic isoflavonoid NV-07a to human skin also markedly
enhanced epidermal MT expression. The NV-07a has been reported previously to protect humans against the
UV suppression of Mantoux reactions. Thus, epidermal MT expression appears to protect against
photoimmunosuppression in both human and mouse skin. We speculate that equol and its related derivative
NV-07a may activate the MT gene synergistically with SSUV, to produce the enhanced immunoprotective effect.
Journal of Investigative Dermatology (2006) 126, 198–204. doi:10.1038/sj.jid.5700013
INTRODUCTION
The flavonoids comprise a group of phytochemicals that have
useful biological activities including anti-cancer and anti-
inflammatory effects (Middleton and Kandaswami, 1992;
Adlercreutz, 1995), generally agreed to result from their
potential as antioxidants. One such isoflavone, 40,7-dihy-
droxyisoflavane (equol), which is a natural metabolite of the
primary isoflavone daidzein, has been found to have strong
protective effects against UV irradiation of mouse skin. In the
hairless mouse irradiated acutely with solar-simulated UV
radiation (SSUV), topically applied equol reduced both the
resultant cutaneous inflammation and the suppression of the
contact hypersensitivity (CHS) reaction (Widyarini et al.,
2001). The immunoprotection appeared to result from equol
inhibiting the downstream actions of the immunosuppressive
UV photoproduct in the skin, cis-urocanic acid. Topical
equol has also been found to reduce the severity of mouse
skin carcinogenesis induced by chronic exposure to SSUV
(Widyarini et al., 2005), which is consistent with its
photoimmunoprotective activity (Reeve and Ley, 2004).
Additionally, a synthetic derivative of equol, the isoflavonoid
NV-07a, has recently been reported to reduce the SSUV-
induced suppression of the Mantoux reaction in a cohort of
humans. The report provides the first indication that this
isoflavonoid applied topically may have useful photoimmu-
noprotective properties in humans (Friedmann et al., 2004).
Although isoflavonoids including equol have been demon-
strated to have significant antioxidant activity (Mitchell et al.,
1998), the mechanisms by which they mediate these UV-
protective effects have remained unclear.
In this study, we examine the possibility that isoflavonoid
photoprotection might result from an interaction with
endogenous cutaneous antioxidants that have been estab-
lished as playing a role in protection against UV radiation
effects. The metallothioneins (MTs) comprise one class of
candidate molecule. These small highly conserved sulfydryl-
rich proteins are best recognized for their function in
maintaining zinc homeostasis, and in chelating and detoxify-
ing environmental heavy metal pollutants. Four isoform
families of MTs have been described, but most is known
about the co-ordinately expressed MT-I and -II. They have
regulating effects on cell proliferation, apoptosis, and the
cellular redox balance due to their antioxidant properties
(Miles et al., 2000). The MTs are readily inducible, typically
by heavy metals and by various oxidative stressors including
UV radiation. Evidence has been accumulating for a
photoprotective function of induced MT in both cultured
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cells and in the skin (Hanada et al., 1991; Hanada et al.,
1993). In mice with a targeted mutation of the MT-I and -II
genes, UVB irradiation resulted in a reduction in apoptotic
sunburn cells (Hanada et al., 1998), an increased suscept-
ibility to the suppression of CHS, and an exacerbated
inflammatory sunburn reaction (Reeve et al., 2000). The
photoprotective mechanism of MT appears to be associated
with its ability to reduce oxidative radicals in the skin, and a
role for cutaneous MT as an important endogenous antiox-
idant is therefore indicated (Hanada et al., 1993).
Here, we report experiments in mice and humans in
which an MT involvement in the photoimmunoprotective
effects of topically applied isoflavonoid lotions was sought.
Immune status was measured in the mice by the CHS
reaction, and immunohistochemical evidence for cutaneous
MT expression was sought in both murine and human skin.
RESULTS
Effect of topical equol on SSUV- and cis-urocanic acid-induced
suppression of CHS in mice
Irradiation on 3 consecutive days with SSUV suppressed the
CHS reaction to oxazolone in both wild-type and MT/
mice; however, the MT/ mice were significantly more
sensitive, as has been reported previously (Reeve et al.,
2000), developing a greater degree of immunosuppression
(62% suppression) than the MTþ /þ mice (42% suppression)
(Figure 1; Po0.001). Topical application alone of equol
lotions containing between 2.5 and 10 mM equol did not
significantly affect the CHS reaction, but produced an equol
concentration-dependent reduction in the severity of the
immunosuppression in the SSUV-irradiated MTþ /þ mice
(Figure 1). Thus, treatment post-irradiation with the highest
test concentration, 10 mM equol, resulted in only 14%
suppression of CHS. This protective effect was absent in
MT/ mice and these remained severely immunosup-
pressed by the SSUV (62–74% suppression of CHS).
When the mice were treated topically with exogenous cis-
urocanic acid, the immunosuppression-mediating cutaneous
photoproduct, there was again significantly (Po0.001) great-
er suppression of CHS in MT/ mice (69% suppression)
than in MTþ /þ mice (58% suppression), as reported
previously (Reeve et al., 2000; Figure 2). Consistent with
the effect in SSUV-immunosuppressed mice, topical 10 mM
equol lotion was strongly protective against cis-urocanic acid
in MTþ /þ mice and reduced the degree of suppression to
29%. In contrast, MT/ mice treated with cis-urocanic acid
and equol remained 72% immunosuppressed.
Effect of topical 10 mM equol and SSUV on MT expression
in mouse skin
Reverse transcriptase-polymerase chain reaction detection of
MT-I mRNA was compared with the housekeeping gene
heme oxygenase-2, the bands were analyzed semi-quantita-
tively in duplicate, and the average ratios of MT-I/heme
oxygenase-2 were calculated for three mice and are shown in
Figure 3. MT-I gene expression was detectable in normal
mouse skin, and was increased modestly but significantly
(Po0.05) by 6% at 3 hours post-SSUV. Equol lotion applica-
tion alone in the absence of SSUV did not alter MT-I mRNA
level, but when SSUV irradiation was followed by equol
lotion application, MT-I mRNA expression was increased by
11% (Po0.05). This mRNA induction appeared to be greater
than the induction in response to SSUV alone; however,
the enhancement did not attain statistical significance (paired
t-test).
Immunopositive MT protein was very weakly evident in
the normal mouse epidermis (Figure 4). However, at 72 hours
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Figure 1. Average contact hypersensitivity responses in groups of five
MTþ /þ or MT/ mice irradiated (or not) with SSUV, followed by topical
applications of base lotion or equol lotions of increasing concentration. Bars
represent SEM. %I/S¼% immunosuppression.
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Figure 2. Average contact hypersensitivity responses in groups of five MTþ /þ
or MT/ mice treated (or not) with topical cis-urocanic acid (c-UCA),
followed by topical applications of base lotion or 10.0 lM equol lotion. Bars
represent SEM.
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– post-SSUV, when the epidermal hyperplasia is well
developed and MT expression has been reported to be
maximal (Nishimura et al., 2000) – there was significant but
discontinuous expression of MT in the epidermal basal layer
cells. Mouse skin treated only with equol lotion was not
different at 72 hours from untreated normal skin, but when
equol lotion was applied following SSUV irradiation, there
was strong enhancement of the MT expression in the
epidermal basal cells compared with the response to SSUV
alone. This treatment also protected against the development
of the epidermal hyperplasia seen following SSUV alone.
Occasional immunopositive dendritic cells were found in the
dermis following SSUV exposure, but were much less evident
in the dermis of SSUVþ equol-treated skin.
Effect of topical 200 mM NV-07a and SSUV on MT expression in
human skin
Human skin was found to express MT constitutively in
approximately 50% of epidermal basal cells, but not in the
suprabasal layers (Figure 5). At 24 hours post-SSUV, a time
point when UV-induced epidermal MT has been reported to
have reached a plateau in human skin (Anstey et al., 1996;
Ablett et al., 2003), there was apparent enhancement of MT
expression and an increase in the percentage of positive-
staining epidermal cells in two of five subjects. SSUV
exposure also induced a number of immunopositive cells
with dendritic appearance in the dermis of all the subjects.
However, in all five subjects, treatment with NV-07a lotion
application following SSUV exposure resulted in a marked
increase in epidermal MT expression, both in intensity and in
immunopositive cell number, with the MT staining extending
from the basal layer into the suprabasal epidermal strata. On
the other hand, the SSUV-elevated percentage of MT-
expressing dermal dendritic cells, illustrated at a higher
magnification in Figure 5, was not further enhanced by
topical NV-07a lotion. Counting of immunopositive epider-
mal cells revealed an increase of between 0 and 11% in
response to SSUV at 24 hours, not statistically significant
(paired t-test), but a marked and statistically significant
increase of between 7 and 26%, averaging 16% increase
(P¼0.007) when SSUV was followed by NV-07a lotion
application (Table 1).
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Figure 3. Semi-quantitative image analysis of average MT-1 mRNA in mouse
skin, normalized against heme oxygenase-2. Mice were treated with base
lotion (BL), SSUV, 10.0 mM equol lotion (equol), or SSUVþ equol lotion. Bars
represent SD for n¼3 mice.
Base lotion SSUV+Base lotion
Equol lotion SSUV+equol lotion
Figure 4. Immunohistochemical identification of MT in mouse skin (brown
staining) treated topically with base lotion or 10 lM equol lotion, before and
at 72 hours post-SSUV exposure. Staining indicates immunopositive basal
epidermal cells post-SSUV, with strongly enhanced epidermal staining after
SSUVþ equol lotion. Dermal dendritic cells expressed MT following SSUV,
but were less evident following SSUVþ equol lotion. Magnification  20.
Nil SSUV+Base lotion
SSUV+Base lotion (dermis)
SSUV+NV-07 lotion
Figure 5. Immunohistochemical identification of MT in human skin (red
staining) before treatment (Nil) and at 24 hours post-SSUV followed by base
lotion or 200 lM NV-07a lotion. Staining indicates constitutive basal
epidermal MT expression in untreated skin, increased epidermal staining post-
SSUV, and strongly enhanced epidermal staining after SSUVþNV-07a lotion.
Dermal dendritic cells expressed MT following SSUV as well as SSUVþNV-
07a. Magnification  20; dermis 40.
Table 1. Enumeration by light microscopy of
per-centage7SD of MT-positive cells in human
epidermis (n=5) and dermis (n=3) at 24 h post-SSUV
Treatment % Epidermal cells
% Dermal dendritic
cells
Nil 52.276.7* 5.471.8**
SSUV+base lotion 53.674.0 33.574.8**
SSUV+NV-07a lotion 68.277.6* 29.7713.5
*P=0.007; **Po0.001.
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DISCUSSION
This study has shown that in normal (MTþ /þ ) haired mice,
moderately inflammatory SSUV exposure that caused significant
suppression of the CHS reaction induced MT-positive dendritic
cells in the dermis at 72hours, and an increase in MT expression
in the basal epidermis. The topical application of equol lotions
following SSUV exposure had several effects: equol attenuated
the SSUV-induced hyperplasia of the epidermal layer, attenuated
the suppression of CHS, and significantly increased the presence
of epidermal MT, but inhibited the expression of MT in dermal
dendritic cells. Furthermore, the capacity of topical equol lotions
to attenuate the suppression of CHS by SSUV was abrogated in
the absence of MT-I and -II (MT/ mice). In untreated mouse
skin, MT was only very weakly expressed, and equol lotion
application alone did not appear to upregulate MT expression.
In humans, in agreement with the observations in mice,
SSUV exposure at a similarly moderately erythemogenic dose
that had previously been shown to suppress the Mantoux
reaction (Friedmann et al., 2004) induced MT-positive
dendritic cells in the dermis at 24 hours. Post-SSUV topical
application of NV-07a lotion dramatically increased the
presence of epidermal MT. In contrast to the mouse skin, MT
was consistently expressed in the basal epidermal cells of
untreated human skin from non-sun-exposed areas. It was not
clear that epidermal thickness was altered by SSUV or NV-
07a. Although two of five subjects did show an increase,
SSUV itself did not cause a statistically significant increase in
the level of epidermal MT expression. Additionally, NV-07a
lotion post-SSUV did not appear to reduce the number of MT-
positive dermal dendritic cells. The continuing presence of
MT-positive dermal cells in human skin treated with
SSUVþNV-07a, but apparent absence in the mouse dermis,
may be related to the failure to observe a reduction in the
human inflammatory erythema reaction by the treatment
at this study time point and in a previous study (Friedmann
et al., 2004). On the other hand, topical equol lotions
have been demonstrated to reduce the inflammatory reaction
in mice (Widyarini et al., 2001), suggesting that it is
epidermal MT expression that is associated with immuno-
protection from SSUV, consistent with this localization of the
important photoreceptor for immunosuppression, trans-uro-
canic acid.
In this study, the very weak MT expression in the normal
mouse skin was in agreement with previous observations in
normal-haired mice (Nishimura et al., 2000), but differed
from the universal expression of MT, predominantly in basal
keratinocytes in untreated human skin, which was in
agreement with other reports (Van den Oord and De Ley,
1994; Anstey et al., 1996; Santucci et al., 2000). We found
MT expression in approximately 50% of the epidermal cells
of untreated human skin in non-sun-exposed sites, which
may indicate a constitutive response to environmental factors
from which laboratory mice are protected. The expression of
MT at distant non-exposed sites in sun-irradiated humans has
been reported recently (Ablett et al., 2003).
Following a single exposure of UVB radiation from a
fluorescent tube source, normal-haired mice have been
reported to continue to respond with increasing cutaneous
MT expression until 72 hours (Nishimura et al., 2000).
Therefore, this time point was selected to examine irradiated
MTþ /þ mice. In that study, unfiltered UVB radiation had
induced MT initially in the dermal fibroblasts of the mouse,
with increasing expression developing in dermal inflammatory
cells and then in the epidermal basal layer. In human skin,
narrow band UVB radiation at 300 nm was also reported to
induce MT expression initially in the superficial dermis from
2 hours post-irradiation, with increased expression encom-
passing the basal epidermal keratinocytes that fluctuated
between 8 and 48 hours (Anstey et al., 1996). Therefore,
the earlier time point of 24 hours was selected to examine
MT expression in humans. It is notable that at these test
time points, using SSUV exposure rather than the UVB of the
earlier studies, we did not observe a predominance of MT
expression in dermal fibroblasts. The basal epidermal cells
appeared to be the major responders in both mice and
humans. Thus, there may be important spectral determinants
for the target cell populations. The predominantly epidermal
expression of SSUV-induced MT is consistent with previous
observations in sunlight-exposed human skin (Ablett et al.,
2003).
In mice, this study has demonstrated the dependence of
the photoimmunoprotection by equol on the induction of
MT. The immunohistochemical evidence for marked upre-
gulation of MT expression in the murine and human
epidermis following SSUVþ equol and NV-07a, respectively,
supports such a role. When the previously established
protective effect of topical NV-07a against the SSUV
suppression of the Mantoux reaction in humans is considered
(Friedmann et al., 2004), it seems very likely that MT
expression in the skin provides an important protective
mechanism against photoimmunosuppression in both mouse
and human. This pathway appears to be significantly
enhanced following equol or NV-07a administration.
Interestingly, equol lotion alone did not affect MT
expression, at least in the mouse, nor did it have an
immunomodulating effect. Therefore, it is unclear how these
isoflavonoids might stimulate MT inducibility by SSUV.
Regulation of the MT genes has been reported to involve
metals, steroid hormones, redox-active molecules, and
various cytokines (Sciavolino and Vilcek, 1995; Nishimura
et al., 2000; Ablett et al., 2003), some recognized also as UV-
released mediators on the skin. A small number of reports
have linked other isoflavones with both direct and indirect
metal-mediated MT induction in cultured cell systems
(Kameoka et al., 1999; Kuo and Leavitt, 1999; Kuo et al.,
2001), implying possible synergism with secondary response
elements (Hua et al., 2003). Future studies may define these
mechanisms better.
In conclusion, our results are consistent with the hypoth-
esis that the photoprotection afforded by topical equol and
NV-07a is dependent on the level of cutaneous MT
expression, in both mouse and human skin. This implicates
these isoflavonoids as exogenous antioxidants, in a role
interacting with the endogenous cellular antioxidant activity
of the skin for a protective outcome. Whether the induction of
cutaneous MT persists in chronically UV-irradiated skin, and
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whether this MT might attenuate photoaging and/or photo-
carcinogenesis, will be the subject of further studies.
MATERIALS AND METHODS
Mice
The MT-I and -II null mouse (Michalska and Khoo, 1993), which
appears phenotypically normal, and its matched wild-type MTþ /þ ,
derived from a C57Bl/6–Ola129 cross, were obtained from the
Veterinary Science breeding colony. They were maintained in
conventional wire-topped plastic caging on compressed paper
bedding, at 251C, and were fed normal laboratory rodent stockfeed
(Gordons Specialty Stockfeeds, Yanderra, Australia) and tap water ad
lib. The studies were conducted according to the NSW Animal
Welfare Act, with approval from the University of Sydney Animal
Ethics Committee. Female mice aged 8–10 weeks were clipped free
of dorsal fur (Oster clippers, Oster Manufacturing, Milwaukee, WI)
24 hours before beginning topical treatment. Mice were selected for
inclusion in experiments when in the resting phase (pink skin) of the
hair growth cycle.
Human volunteers
Five volunteers (age range 30–59 years, one woman) were recruited.
Participants were healthy volunteers with skin type I or II (ie fair skin,
which tans poorly and burns on exposure to the sun). Potential
participants with bleeding diathesis, or those who were taking
anti-coagulant therapy or medications known or suspected to
reduce inflammation, immunity, or healing (eg corticosteroids),
or those who had any chronic disease requiring ongoing medical
attention, were excluded. The study was conducted according
to the Declaration of Helsinki Principles and was approved by
the Human Research Ethics Committee of the Queensland Institute
of Medical Research and all participants gave their informed
consent.
SSUV radiation
SSUV was provided by a planar bank of six 120 cm fluorescent UVA
tubes (Hitachi 40W F40T 10/BL, black light, Tokyo, Japan) flanking
one UVB tube (Philips TL 40W/12RS, Eindhoven, The Netherlands),
with radiation filtered through a sheet of 0.125 mm cellulose acetate
(Eastman Chemical Products, Kingsport, TN). This radiation source
emits 2.82 102 W/cm2 UVA (320–400 nm) and 9.14 104 W/
cm2 UVB (290–320 nm), when measured with an Optronics OL754
integrating spectroradiometer (Orlando, FL). The spectral character-
istics of this light source have been described previously (Reeve
et al., 1985). The cellulose acetate filter efficiently removes
wavelengths o290 nm and results in a good approximation of the
solar UV waveband.
Groups of up to five mice, unrestrained with their cage tops
removed, received whole dorsal irradiation of a single moderately
erythemogenic dose of 2.5minimum erythemal dose (MED;
established for the MTþ /þ mouse), providing 3.32 kJ/m2 UVB, or
a series of incremental daily exposures of SSUV providing 1.99,
2.65, and 3.32 kJ/m2 UVB on days 1–3 to produce significant
immunosuppression without burning. Human subjects were posi-
tioned centrally directly beneath the light source and remained
prone and still for the duration of exposure. All skin surfaces were
covered, except for the test sites. They received a single exposure to
the lower back of 2.5 MED, calculated from their MED previously
established from a graded series of incremental exposures from the
SSUV source at a separate skin site.
Topical lotion
Equol was purchased from Sigma Chemical Co. (Sigma-Aldrich
Australia, Castle Hill, Australia). NV-07a was synthesized as a racemic
mixture of 40,7-dihydroxyisoflavane by Novogen Ltd (North Ryde,
Australia). The compounds were each dissolved in DMSO, then
diluted to the required concentration in an innocuous oil-in-water
cosmetic lotion as described previously (Widyarini et al., 2001, 2005),
without color, perfume, or preservative, so that the final lotion
contained various concentrations of isoflavonoids and 0.5% (vol/vol)
DMSO. The isoflavonoid concentration used was considerably higher
for humans than for mice, based on previous studies of NV-07a
effectiveness on human skin (Friedmann et al., 2004). The control
lotion (‘‘base lotion’’) contained only 0.5% DMSO in the emulsion.
The lotions were stored refrigerated in the dark.
Treatment protocol
Mice. For assay of the activation of the MT-I gene, groups of three
MTþ /þ mice were exposed to a single dose of 2.5 MED of SSUV,
or remained unirradiated. An aliquot of 0.1 ml of 10 mM equol or
base lotion was applied to the dorsum immediately and again at 0.5
and 1 hours post-irradiation. The mice were killed and mid-dorsal
skin was excised for total RNA extraction at 3 hours. For
immunohistochemical detection of MT-I and -II protein expression,
these treatments were repeated with 10 mM equol or base lotion
applications immediately and at 4 and 6 hours post-SSUV. Skin
samples were taken at 72 hours post-SSUV, as MT expression in
mouse skin has been reported to continue to increase until 72 hours
(Nishimura et al., 2000).
For assay of CHS, groups of five MTþ /þ and five MT/ mice
were irradiated on days 1–3 with incremental doses of 1.5, 2.0, and
2.5 MED of SSUV. Immediately following each irradiation, 0.1 ml
lotion containing 0, 2.5, 5.0, or 10.0 mM equol was applied to the
dorsal skin. When cis-urocanic acid replaced the SSUV treatment for
the induction of immunosuppression, 0.1 ml of a lotion containing
0.2% photoisomerized urocanic acid (Reeve et al., 1993), here
referred to as ‘‘cis-urocanic acid lotion’’, was applied to the dorsum
daily on days 1–3, and was followed at 30 minutes with 0.1 ml base
lotion or 10.0mM equol lotion each day. The lotions were lightly
spread over the entire dorsal area with a gloved finger, and the mice
held on the wire cage tops to discourage grooming for 15 minutes,
until the lotions were absorbed.
Human volunteers. For the identification of cutaneous MT protein
expression, three skin sites, each of area 5 cm2, were delineated on
the lower back, an area not normally exposed to sunlight, of which
two were exposed to 2.5 MED of SSUV and one remained protected
by an aluminum mask. Following exposure, the irradiated areas
were treated topically with 0.1 ml of base lotion, or 0.1 ml of 200 mM
NV-07a lotion. The NV-07a or base lotion was applied immediately,
at 4 hours and again at 6 hours post-SSUV, spread lightly over the
area and allowed to be absorbed by the skin. We elected not to
include treatment with topical NV-07a lotion and without SSUV
irradiation, owing to ethical constraints on the number of biopsies to
be taken from each subject. Skin biopsies were obtained aseptically
using disposable, single-use, sterile 3 mm dermal biopsy punches
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from the untreated skin site, and at 24 hours following SSUV
exposure. UVB has been reported to induce MT in human epidermis
at levels fluctuating between 8 and 48 hours (Anstey et al., 1996).
Measurement of the CHS reaction in mice
The CHS reaction to oxazolone was induced in groups of five mice
by sensitization on the unirradiated abdominal skin on days 8 and 9,
and the mice were challenged on the pinnae on day 15, as described
previously (Reeve, 2002). Ear thickness was measured before and
repeatedly between 16 and 24 hours after the challenge, using a
spring micrometer (Interapid, Geneva, Switzerland), and the average
ear swelling for each group was calculated at the time of peak ear
thickness in the control group (receiving base lotion only).
Significance of the differences between treatments was assessed by
the paired t-test.
Identification of MT mRNA in mouse skin by reverse tran-
scriptase-polymerase chain reaction
Murine MT-1 cDNA sequence (accession no. NM_013602) and
murine heme oxygenase-2 cDNA sequence (accession no.
AF029874) can be located on the GenBank website (http://
www.ncbi.nlm.nih.gov/). MT-1 primers were designed (forward 50-
ACCCCAACTGCTCCTGCT-30 and reverse 50-GCGCCTTTGCAGA
CACAG-30) to provide a 154 bp PCR product. Primers for heme
oxygenase-2, used as a control housekeeping gene, were designed
(forward 50-GAAGGAAGGGACCAAGGAAG-30 and reverse 50-
GTTTTAGGCAGAGGTGGAGATG-30) to generate 767 bp PCR
products. The primers were synthesized by Invitrogen Life Technol-
ogies (Melbourne, Australia).
Mid-dorsal skin samples 1 2 cm were taken from groups of
three treated MTþ /þ mice, killed before and at 3 hours post-SSUV,
and total RNA was extracted, facilitated by cutting the skin sample
into 10mm slices with a cryostat at 201C, and using the SV total
RNA isolation system (Promega, Madison, WI). The RNA was reverse
transcribed using the reverse transcription system (Promega A3500)
and amplified using a Hybaid OmniGene thermal cycler (State
Agricultural Biotechnology Centre, Murdoch, Australia). The PCR
products were resolved together with a DNA molecular weight
marker (GeneRuler 1 kb DNA ladder, Gronigen, The Netherlands)
electrophoretically on a 1.2% agarose gel containing ethidium
bromide, as described previously (Allanson and Reeve, 2004). Gels
were photographed under UV light (Kodak DC120 Digital camera,
Kodak Australia Pty. Ltd, Coburg, Australia) and the images were
analyzed using the ‘‘Quantity One’’ (BioRad version 4.1.1) program.
MT-I was semi-quantitated after normalization with respect to the
constitutively expressed heme oxygenase-2, and averaged for three
mice, following SSUV treatments with base lotion or 10 mM equol
lotion application as described above.
Immunohistochemical identification of MT (mouse and human
skin)
Groups of three MTþ /þ mice were killed before and at 72 hours
after SSUV exposure, and a transverse mid-dorsal sample was taken.
Human skin was obtained before and at 24 hours following SSUV
irradiation. Both mouse and human skin samples were fixed for
6 hours in Histochoice (Amresco, Parkway, OH), processed over-
night with a formalin-based automated methodology, and paraffin-
embedded.
In the mouse, MT protein was revealed in 4mm skin sections,
using a polyclonal rabbit anti-rat MT-I and -II antibody with color
development using the 3,30-diaminobenzidine chromogen (Dako,
Carpinteria, CA) as described previously (Nishimura et al., 2000). A
monoclonal mouse anti-human MT antibody that reacts against a
conserved N-terminal epitope shared by MT-I and -II (clone E9;
Dako, Carpinteria, CA) was used in the human biopsies, with citric
acid and microwave treatment for antigen retrieval, and color
development with 3-amino-9-ethylcarbazole (Sigma) (Ablett et al.,
2003). The sections were examined by light microscopy and
the images captured digitally by camera. The greater cellularity
of human epidermis allowed for the enumeration of the percentage
of positive -staining cells in three representative non-overlapping
fields.
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